TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 RISING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL & BIOTECHNOLOGICAL SECTORS
4.2.2 GROWING R&D INITIATIVES IN THE PHARMACEUTICAL INDUSTRY
4.3 RESTRAINTS
4.3.1 COMPLEX AND VARIED PHARMACEUTICAL ISOLATOR REGULATIONS ACROSS COUNTRIES
4.3.2 SHORTAGE OF TRAINED AND EXPERIENCED MEDICAL SPECIALISTS
4.4 OPPORTUNITY
4.4.1 INCREASING ADOPTION OF PHARMACEUTICAL ISOLATORS IN EMERGING ECONOMIES
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS
5.1.1 R&D AND DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION, MARKETING, AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT ANALYSIS OF COVID-19 ON PHARMACEUTICAL ISOLATOR MARKET
5.3.1 OVERVIEW
5.3.2 IMPACT ON SUPPLY CHAIN
5.3.3 IMPACT ON PRODUCTION
5.3.4 IMPACT ON REGIONS
5.3.5 DEMAND SUPPLY GAP ANALYSIS
6 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY TYPE
6.1 OVERVIEW
6.2 OPEN ISOLATOR
6.3 CLOSED ISOLATOR
7 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 STERILITY TEST ISOLATOR
7.3 PROCESS ISOLATOR
7.4 DECONTAMINATION PASS BOX
8 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS
8.1 OVERVIEW
8.2 ISO CLASS 3
8.3 ISO CLASS 5
9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 STERILITY TESTING
9.3 SAMPLING/ WEIGHING/ DISTRIBUTION
9.4 ANIMAL LABORATORIES
9.5 ASEPTIC TISSUE HANDLING/MICROBIOLOGY TESTING/PATHOGENIC SAMPLING
9.6 DEFILTRATION AND DRYING
9.7 OTHERS
10 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY END USER
10.1 OVERVIEW
10.2 BIOPHARMA/CELL & GENE THERAPY COMPANIES
10.3 ACADEMIC & RESEARCH INSTITUTES
10.4 HOSPITALS
10.5 CONTRACT RESEARCH ORGANIZATION & CONTRACT MANUFACTURING ORGANIZATION
11 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 FRANCE
11.3.3 UK
11.3.4 ITALY
11.3.5 SPAIN
11.3.6 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 JAPAN
11.4.2 CHINA
11.4.3 INDIA
11.4.4 AUSTRALIA
11.4.5 SOUTH KOREA
11.4.6 REST OF ASIA-PACIFIC
11.5 REST OF THE WORLD
11.5.1 MIDDLE EAST
11.5.2 AFRICA
11.5.3 LATIN AMERICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 COMPETITIVE BENCHMARKING
12.3 MAJOR GROWTH STRATEGY IN THE PHARMACEUTICAL ISOLATOR MARKET
12.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE PHARMACEUTICAL ISOLATOR MARKET
12.5 KEY DEVELOPMENT ANALYSIS
12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
12.6.1 EXPANSION/AGREEMENT
12.6.2 MERGERS & ACQUISITIONS
12.6.3 SALES
13 COMPANY PROFILES
13.1 SKAN AG
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL OVERVIEW
13.1.3 PRODUCTS OFFERED
13.1.4 KEY DEVELOPMENTS
13.1.5 SWOT ANALYSIS
13.1.6 KEY STRATEGIES
13.2 AZBIL TELSTAR S.L.U
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL OVERVIEW
13.2.3 PRODUCTS OFFERED
13.2.4 KEY DEVELOPMENTS
13.2.5 SWOT ANALYSIS
13.2.6 KEY STRATEGIES
13.3 CYTIVA
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL OVERVIEW
13.3.3 PRODUCTS OFFERED
13.3.4 KEY DEVELOPMENTS
13.3.5 SWOT ANALYSIS
13.3.6 KEY STRATEGIES
13.4 NUAIRE INC.
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL OVERVIEW
13.4.3 PRODUCTS OFFERED
13.4.4 KEY DEVELOPMENTS
13.4.5 SWOT ANALYSIS
13.4.6 KEY STRATEGIES
13.5 SCHEMATIC ENGINEERING INDUSTRIES
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL OVERVIEW
13.5.3 PRODUCTS OFFERED
13.5.4 KEY DEVELOPMENTS
13.5.5 SWOT ANALYSIS
13.5.6 KEY STRATEGIES
13.6 MBRAUN GMBH
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL OVERVIEW
13.6.3 PRODUCTS OFFERED
13.6.4 KEY DEVELOPMENTS
13.6.5 KEY STRATEGIES
13.7 FEDEGARI AUTOCLAVI S.P.A
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL OVERVIEW
13.7.3 PRODUCT OFFERED
13.7.4 KEY DEVELOPMENTS
13.7.5 KEY STRATEGIES
13.8 HOSOKAWA MICRON B.V.
13.8.1 COMPANY OVERVIEW
13.8.2 FINANCIAL OVERVIEW
13.8.3 PRODUCTS OFFERED
13.8.4 KEY DEVELOPMENTS
13.8.5 SWOT ANALYSIS
13.8.6 KEY STRATEGIES
13.9 SYNTEGON TECHNOLOGY
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL OVERVIEW
13.9.3 PRODUCTS OFFERED
13.9.4 KEY DEVELOPMENTS
13.9.5 SWOT ANALYSIS
13.9.6 KEY STRATEGIES
13.10 ISOTECH DESIGN
13.10.1 COMPANY OVERVIEW
13.10.2 FINANCIAL OVERVIEW
13.10.3 PRODUCTS OFFERED
13.10.4 KEY DEVELOPMENTS
13.10.5 KEY STRATEGIES
13.11 GETINGE AB
13.11.1 COMPANY OVERVIEW
13.11.2 FINANCIAL OVERVIEW
13.11.3 PRODUCTS OFFERED
13.11.4 KEY DEVELOPMENTS
13.11.5 KEY STRATEGIES
14 APPENDIX
14.1 REFERENCES
14.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 4 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR OPEN ISOLATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 5 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR CLOSED ISOLATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 6 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET FOR STERILITY TEST ISOLATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR PROCESS ISOLATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 9 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR DECONTAMINATION PASS BOX, BY REGION, 2018-2030 (USD MILLION)
TABLE 10 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 11 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET FOR ISO CLASS 3, BY REGION, 2018-2030 (USD MILLION)
TABLE 12 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR ISO CLASS 5, BY REGION, 2018-2030 (USD MILLION)
TABLE 13 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET FOR STERILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR SAMPLING/ WEIGHING/ DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR ANIMAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR ASEPTIC TISSUE HANDLING/MICROBIOLOGY TESTING/PATHOGENIC SAMPLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR DEFILTRATION AND DRYING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR OTHERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 21 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET FOR BIOPHARMA/CELL & GENE THERAPY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR CRO & CMO, BY REGION, 2018-2030 (USD MILLION)
TABLE 25 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 26 NORTH AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27 NORTH AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28 NORTH AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 29 NORTH AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 30 NORTH AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31 NORTH AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 32 US: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33 US: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 34 US: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 35 US: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36 US: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 37 CANADA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38 CANADA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39 CANADA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 40 CANADA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41 CANADA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 42 EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43 EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44 EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45 EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 46 EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47 EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 48 GERMANY: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49 GERMANY: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50 GERMANY: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 51 GERMANY: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52 GERMANY: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 53 FRANCE: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54 FRANCE: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55 FRANCE: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 56 FRANCE: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57 FRANCE: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 58 UK: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59 UK: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60 UK: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 61 UK: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62 UK: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 63 ITALY: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64 ITALY: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65 ITALY: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 66 ITALY: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67 ITALY: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 68 SPAIN: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69 SPAIN: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70 SPAIN: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 71 SPAIN: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72 SPAIN: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 73 REST OF EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74 REST OF EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75 REST OF EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 76 REST OF EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77 REST OF EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 78 ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79 ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80 ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81 ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 82 ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83 ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 84 JAPAN: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85 JAPAN: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86 JAPAN: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 87 JAPAN: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88 JAPAN: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 89 CHINA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90 CHINA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91 CHINA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 92 CHINA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93 CHINA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 94 INDIA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95 INDIA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96 INDIA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 97 INDIA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98 INDIA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 99 AUSTRALIA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100 AUSTRALIA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101 AUSTRALIA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 102 AUSTRALIA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103 AUSTRALIA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 104 SOUTH KOREA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105 SOUTH KOREA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106 SOUTH KOREA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 107 SOUTH KOREA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108 SOUTH KOREA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 109 REST OF ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110 REST OF ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111 REST OF ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 112 REST OF ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113 REST OF ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 114 REST OF THE WORLD: PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 115 REST OF THE WORLD: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116 REST OF THE WORLD: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117 REST OF THE WORLD: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 118 REST OF THE WORLD: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119 REST OF THE WORLD: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 120 MIDDLE EAST: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121 MIDDLE EAST: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122 MIDDLE EAST: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 123 MIDDLE EAST: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124 MIDDLE EAST: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 125 AFRICA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126 AFRICA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127 AFRICA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 128 AFRICA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129 AFRICA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 130 LATIN AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131 LATIN AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132 LATIN AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)
TABLE 133 LATIN AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134 LATIN AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 135 MAJOR MANUFACTURERS IN COMPANION DIAGNOSTIC MARKET
TABLE 136 MOST ACTIVE PLAYER IN THE PHARMACEUTICAL ISOLATOR MARKET
TABLE 137 EXPANSION/AGREEMENT
TABLE 138 MERGERS & ACQUISITIONS
TABLE 139 SKAN AG: PRODUCTS OFFERED
TABLE 140 SKAN AG: KEY DEVELOPMENTS
TABLE 141 AZBIL TELSTAR S.L.U: PRODUCTS OFFERED
TABLE 142 CYTIVA: PRODUCTS OFFERED
TABLE 143 CYTIVA: KEY DEVELOPMENTS
TABLE 144 NUAIRE INC.: PRODUCTS OFFERED
TABLE 145 SCHEMATIC ENGINEERING INDUSTRIES: PRODUCTS OFFERED
TABLE 146 MBRAUN GMBH: PRODUCTS OFFERED
TABLE 147 FEDEGARI AUTOCLAVI S.P A: PRODUCTS OFFERED
TABLE 148 HOSOKAWA MICRON B.V.: PRODUCTS OFFERED
TABLE 149 SYNTEGON TECHNOLOGY: PRODUCTS OFFERED
TABLE 150 ISOTECH DESIGN: PRODUCTS OFFERED
TABLE 151 GETINGE AB: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL PHARMACEUTICAL ISOLATOR MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: GLOBAL PHARMACEUTICAL ISOLATOR MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 SUPPLY CHAIN ANALYSIS: GLOBAL PHARMACEUTICAL ISOLATOR MARKET
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL PHARMACEUTICAL ISOLATOR MARKET
FIGURE 9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2021 & 2030 (USD MILLION)
FIGURE 10 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY TYPE, 2021
FIGURE 11 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2021 & 2030 (USD MILLION)
FIGURE 12 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY PRODUCT TYPE, 2021
FIGURE 13 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2021 & 2030 (USD MILLION)
FIGURE 14 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY PRODUCT CLASS 2021
FIGURE 15 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2021 & 2030 (USD MILLION)
FIGURE 16 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY APPLICATION 2021
FIGURE 17 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2021 & 2030 (USD MILLION)
FIGURE 18 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY APPLICATION 2021
FIGURE 19 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY REGION 2021 & 2030 (USD MILLION)
FIGURE 20 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY REGION, 2021
FIGURE 21 NORTH AMERICA: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY COUNTRY 2021
FIGURE 22 EUROPE: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY COUNTRY 2021
FIGURE 23 ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY COUNTRY 2021
FIGURE 24 REST OF THE WORLD: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY COUNTRY 2021
FIGURE 25 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 26 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE PHARMACEUTICAL ISOLATOR MARKET
FIGURE 27 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: COMPETITIVE LANDSCAPE
FIGURE 28 MAJOR PLAYERS SALES, 2020
FIGURE 29 SKAN AG: FINANCIAL OVERVIEW
FIGURE 30 SKAN AG: SWOT ANALYSIS
FIGURE 31 AZBIL TELSTAR S.L.U: SWOT ANALYSIS
FIGURE 32 CYTIVA: SWOT ANALYSIS
FIGURE 33 NUAIRE INC.: SWOT ANALYSIS
FIGURE 34 SCHEMATIC ENGINEERING INDUSTRIES: SWOT ANALYSIS
FIGURE 35 HOSOKAWA MICRON B.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 HOSOKAWA MICRON B.V.: SWOT ANALYSIS
FIGURE 37 SYNTEGON TECHNOLOGY.: SWOT ANALYSIS
FIGURE 38 GETINGE AB: FINANCIAL OVERVIEW SNAPSHOT